TYCC
QTTB icon

Texas Yale Capital Corp’s Q32 Bio QTTB Stock Holding History

Texas Yale Capital Corp’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-556
Closed -$6.08K – 455
2023
Q4 		$6.08K Hold
556
– – ﹤0.01% 436
2023
Q3 		$11.7K Hold
556
– – ﹤0.01% 421
2023
Q2 		$8.85K Hold
556
– – ﹤0.01% 441
2023
Q1 		$10.3K Hold
556
– – ﹤0.01% 450
2022
Q4 		$12.6K Hold
556
– – ﹤0.01% 453
2022
Q3 		$16K Hold
556
– – ﹤0.01% 448
2022
Q2 		$20K Hold
556
– – ﹤0.01% 443
2022
Q1 		$30K Hold
556
– – ﹤0.01% 464
2021
Q4 		$36K Hold
556
– – ﹤0.01% 468
2021
Q3 		$79K Hold
556
– – ﹤0.01% 456
2021
Q2 		$73K Hold
556
– – ﹤0.01% 463
2021
Q1 		$94K Buy
+556
New +$117K 0.01% 433

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Texas Yale Capital Corp's QTTB Position: Q1 2024 in Review

Texas Yale Capital Corp sold out of Q32 Bio (QTTB) in Q1 2024, closing a stake of 556 shares — an estimated $6.08K sold.

Texas Yale Capital Corp first reported a position in QTTB in Q1 2021 and held it in 12 quarters. The position peaked at $94K in Q1 2021. 39 funds tracked by Wall St. Rank hold QTTB as of Q1 2024.

  • Texas Yale Capital Corp reported no remaining Q32 Bio position as of Q1 2024 after selling out during the quarter.
  • Texas Yale Capital Corp sold 556 Q32 Bio shares in Q1 2024, an estimated $6.08K.
  • Texas Yale Capital Corp first reported a position in Q32 Bio in Q1 2021 and held it in 12 quarters.
  • Texas Yale Capital Corp's Q32 Bio position peaked at $94K in Q1 2021.
  • 39 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2024.

Based on Texas Yale Capital Corp's 13F filing for Q1 2024, filed 8 May 2024.